51
Participants
Start Date
August 13, 2010
Primary Completion Date
January 8, 2013
Study Completion Date
January 8, 2013
SPD602 (FBS0701, SSP-004184)
Oral FBS0701 taken one time daily for up to 96 weeks.
Children's Hospital and Research Center of Oakland, Oakland
Children's Hospital of Boston, Boston
Ospedale Regionale Microcitemie, Cagliari
Centro della Microcitemia e delle Anemie Congenite, Genoa
Thalassemia Center San Luigi Hospital, Orbassano
Siriraj Hospital, Mahidol University, Bangkok
Pediatric Hematology, Ege University Hospital, Izmir
University College London Hospital, London
Whittington Hospital, London
Lead Sponsor
Shire
INDUSTRY